Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study.
Hoshi M, Kobayashi N, Tanaka K, Somekawa K, Kaneko A, Izawa A, Seki K, Tagami Y, Aoki A, Fujii H, Watanabe K, Horita N, Hara Y, Matsumura M, Enaka M, Hagihara M, Kaneko T. Hoshi M, et al. Among authors: izawa a. Thorac Cancer. 2021 Dec;12(23):3281-3285. doi: 10.1111/1759-7714.14190. Epub 2021 Oct 25. Thorac Cancer. 2021. PMID: 34698453 Free PMC article. Review.
Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019.
Hara Y, Oshima Y, Tagami Y, Aoki A, Fujii H, Izawa A, Seki K, Kanai A, Yabe A, Watanabe K, Horita N, Kobayashi N, Kaneko T. Hara Y, et al. Among authors: izawa a. Respir Med Case Rep. 2022;36:101615. doi: 10.1016/j.rmcr.2022.101615. Epub 2022 Feb 20. Respir Med Case Rep. 2022. PMID: 35223424 Free PMC article.
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.
Matsumoto H, Somekawa K, Horita N, Ueda S, Kaneko M, Kaneko A, Fukuda N, Izawa A, Kamimaki C, Tanaka K, Murohashi K, Fuji H, Tagami Y, Aoki A, Watanabe K, Hara Y, Kobayashi N, Kaneko T. Matsumoto H, et al. Among authors: izawa a. Ther Adv Med Oncol. 2023 Sep 13;15:17588359231198453. doi: 10.1177/17588359231198453. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37720498 Free PMC article. Review.
Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis.
Tagami Y, Horita N, Kaneko M, Muraoka S, Fukuda N, Izawa A, Kaneko A, Somekawa K, Kamimaki C, Matsumoto H, Tanaka K, Murohashi K, Aoki A, Fujii H, Watanabe K, Hara Y, Kobayashi N, Kaneko T. Tagami Y, et al. Among authors: izawa a. J Infect Dis. 2024 May 15;229(5):1481-1492. doi: 10.1093/infdis/jiad480. J Infect Dis. 2024. PMID: 37946558
ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.
Hirata M, Hara Y, Fujii H, Murohashi K, Saigusa Y, Zhao S, Kobayashi M, Nagasawa R, Tagami Y, Izawa A, Otsu Y, Watanabe K, Horita N, Kobayashi N, Kaneko T. Hirata M, et al. Among authors: izawa a. BMC Pulm Med. 2024 Jan 5;24(1):16. doi: 10.1186/s12890-023-02833-6. BMC Pulm Med. 2024. PMID: 38183005 Free PMC article.
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
Izawa A, Hara Y, Horita N, Muraoka S, Kaneko M, Kaneko A, Somekawa K, Hirata M, Otsu Y, Matsumoto H, Nagasawa R, Tanaka K, Kubo S, Murohashi K, Aoki A, Fujii H, Watanabe K, Kobayashi N, Miura K, Nakajima H, Kaneko T. Izawa A, et al. Transl Lung Cancer Res. 2024 Mar 29;13(3):503-511. doi: 10.21037/tlcr-23-855. Epub 2024 Mar 15. Transl Lung Cancer Res. 2024. PMID: 38601457 Free PMC article.
HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumonia.
Tanaka K, Meguro A, Hara Y, Endo L, Izawa A, Muraoka S, Kaneko A, Somekawa K, Hirata M, Otsu Y, Matsumoto H, Nagasawa R, Kubo S, Murohashi K, Aoki A, Fujii H, Watanabe K, Horita N, Kato H, Kobayashi N, Takeuchi I, Nakajima A, Inoko H, Mizuki N, Kaneko T. Tanaka K, et al. Among authors: izawa a. HLA. 2024 Jul;104(1):e15609. doi: 10.1111/tan.15609. HLA. 2024. PMID: 39041300
Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma.
Somekawa K, Watanabe K, Seki K, Muraoka S, Izawa A, Kaneko A, Otsu Y, Hirata M, Kubo S, Tanaka K, Nagasawa R, Matsumoto H, Murohashi K, Fuji H, Aoki A, Horita N, Hara Y, Kobayashi N, Kudo M, Kaneko T. Somekawa K, et al. Among authors: izawa a. Eur Clin Respir J. 2024 Jul 26;11(1):2384173. doi: 10.1080/20018525.2024.2384173. eCollection 2024. Eur Clin Respir J. 2024. PMID: 39077553 Free PMC article.
180 results